Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 8/20 | 0.41 |
| ▸ | TYR | P14679 | 1/20 | 0.39 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.34 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29783451 | 1.00 | TAAR1 (0.41) | TAAR1TYRPTGER3HTR1A | |
| SCHEMBL29783449 | 0.73 | MAPT (0.55) | — | |
| SCHEMBL20865069 | 0.73 | MAPT (0.55) | — | |
| SCHEMBL8958030 | 0.72 | TAAR1 (0.51) | TAAR1HTR1A | |
| SCHEMBL10439615 | 0.72 | ESR1 (0.58) | TAAR1TYR | |
| SCHEMBL9686332 | 0.72 | TYR (0.51) | TYR | |
| SCHEMBL20865071 | 0.71 | TYR (0.39) | TYR | |
| SCHEMBL29783452 | 0.71 | TYR (0.39) | TYR | |
| SCHEMBL20865068 | 0.71 | FDPS (0.41) | TYR | |
| SCHEMBL4289027 | 0.70 | TYR (0.46) | TYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11389385-B2 | Resorcinol derivatives for their cosmetic use | L'OREAL (FR) | 2022-07-19 | — | — | US | claimed |
| EP-3687979-B1 | RESORCINOL DERIVATIVES FOR THEIR COSMETIC USE | OREAL (FR) | 2021-08-18 | — | — | EP | claimed |
| US-20200246240-A1 | RESORCINOL DERIVATIVES FOR THEIR COSMETIC USE | L'OREAL (FR) | 2020-08-06 | — | — | US | claimed |
| US-11389385-B2 | Resorcinol derivatives for their cosmetic use | L'OREAL (FR) | 2022-07-19 | — | — | US | disclosed |
| EP-3687979-B1 | RESORCINOL DERIVATIVES FOR THEIR COSMETIC USE | OREAL (FR) | 2021-08-18 | — | — | EP | disclosed |
| EP-3687979-B1 | RESORCINOL DERIVATIVES FOR THEIR COSMETIC USE | OREAL (FR) | 2021-08-18 | — | — | EP | disclosed |
| US-20200246240-A1 | RESORCINOL DERIVATIVES FOR THEIR COSMETIC USE | L'OREAL (FR) | 2020-08-06 | — | — | US | disclosed |
| US-20200246240-A1 | RESORCINOL DERIVATIVES FOR THEIR COSMETIC USE | L'OREAL (FR) | 2020-08-06 | — | — | US | disclosed |
| WO-2019063710-A1 | RESORCINOL DERIVATIVES FOR THEIR COSMETIC USE | L'OREAL (FR) | 2019-04-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11389385-B2 | Resorcinol derivatives for their cosmetic use | KRT18, RBP4, RARA | TAAR1 3976/4885TYR 16/4885PTGER3 2362/4885 |
| US-20200246240-A1 | RESORCINOL DERIVATIVES FOR THEIR COSMETIC USE | KRT18, RARA, RBP4 | TAAR1 3881/4885TYR 16/4885PTGER3 2599/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.